{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:30:44Z","timestamp":1756895444524},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s12185-012-1232-5","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T06:55:07Z","timestamp":1355813707000},"page":"83-91","source":"Crossref","is-referenced-by-count":3,"title":["Fadd and Skp2 are possible downstream targets of RUNX1-EVI1"],"prefix":"10.1007","volume":"97","author":[{"given":"Kazuhiro","family":"Maki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusako","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinuko","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/j.1460-2075.1994.tb06288.x","volume":"13","author":"K Mitani","year":"1994","unstructured":"Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 1994;13:504\u201310.","journal-title":"EMBO J"},{"key":"1232_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1532\/IJH97.05075","volume":"82","author":"T Yamagata","year":"2005","unstructured":"Yamagata T, Maki K, Mitani K. Runx1\/AML1 in normal and abnormal hematopoiesis. Int J Hematol. 2005;82:1\u20138.","journal-title":"Int J Hematol"},{"key":"1232_CR3","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/sj.onc.1205436","volume":"21","author":"V Senyuk","year":"2002","unstructured":"Senyuk V, Chakraborty S, Mikhail FM, Zhao R, Chi Y, Nucifora G. The leukemia-associated transcription repressor AML1\/MDS1\/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells. Oncogene. 2002;21:3232\u201340.","journal-title":"Oncogene"},{"key":"1232_CR4","doi-asserted-by":"crossref","unstructured":"Takeshita M, Ichikawa M, Nitta E, Goyama S, Asai T, Ogawa S, et al. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1. Leukemia. 2008;22:1241\u20139.","DOI":"10.1038\/leu.2008.53"},{"key":"1232_CR5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/MCB.15.5.2383","volume":"15","author":"T Tanaka","year":"1995","unstructured":"Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, et al. Dual functions of the AML1\/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias. Mol Cell Biol. 1995;15:2383\u201392.","journal-title":"Mol Cell Biol"},{"key":"1232_CR6","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1073\/pnas.030421197","volume":"97","author":"GM Cuenco","year":"2000","unstructured":"Cuenco GM, Nucifora G, Ren R. Human AML1\/MDS1\/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. Proc Natl Acad Sci USA. 2000;97:1760\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/sj.leu.2404281","volume":"20","author":"K Maki","year":"2006","unstructured":"Maki K, Yamagata T, Yamazaki I, Oda H, Mitani K. Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse. Leukemia. 2006;20:1458\u201360.","journal-title":"Leukemia"},{"key":"1232_CR8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12185-011-0858-z","volume":"94","author":"S Goyama","year":"2011","unstructured":"Goyama S, Mulloy JC. Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects. Int J Hematol. 2011;94:126\u201333.","journal-title":"Int J Hematol"},{"key":"1232_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12185-010-0618-5","volume":"91","author":"S Goyama","year":"2010","unstructured":"Goyama S, Kurokawa M. Evi-1 as a critical regulator of leukemic cells. Int J Hematol. 2010;91:753\u20137.","journal-title":"Int J Hematol"},{"key":"1232_CR10","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood.V92.11.4003","volume":"92","author":"M Kurokawa","year":"1998","unstructured":"Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H. The t(3;21) fusion product, AML1\/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood. 1998;92:4003\u201312.","journal-title":"Blood"},{"key":"1232_CR11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1349-7006.2007.00597.x","volume":"98","author":"K Tokita","year":"2007","unstructured":"Tokita K, Maki K, Mitani K. RUNX1\/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function. Cancer Sci. 2007;98:1752\u20137.","journal-title":"Cancer Sci"},{"key":"1232_CR12","first-page":"833","volume":"11","author":"M Kurokawa","year":"1995","unstructured":"Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON, et al. The AML1\/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence. Oncogene. 1995;11:833\u201340.","journal-title":"Oncogene"},{"key":"1232_CR13","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/sj.onc.1205356","volume":"21","author":"K Izutsu","year":"2002","unstructured":"Izutsu K, Kurokawa M, Imai Y, Ichikawa M, Asai T, Maki K, et al. The t(3;21) fusion product, AML1\/Evi-1 blocks AML1-induced transactivation by recruiting CtBP. Oncogene. 2002;21:2695\u2013703.","journal-title":"Oncogene"},{"key":"1232_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/stem.170226","volume":"17","author":"A Kume","year":"1999","unstructured":"Kume A, Hashiyama M, Suda T, Ozawa K. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors. Stem Cells. 1999;17:226\u201332.","journal-title":"Stem Cells"},{"key":"1232_CR15","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","volume":"7","author":"S Morita","year":"2000","unstructured":"Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 2000;7:1063\u20136.","journal-title":"Gene Ther"},{"key":"1232_CR16","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1182\/blood-2004-11-4330","volume":"106","author":"K Maki","year":"2005","unstructured":"Maki K, Yamagata T, Asai T, Yamazaki I, Oda H, Hirai H, et al. Dysplastic definitive hematopoiesis in AML1\/EVI1 knock-in embryos. Blood. 2005;106:2147\u201355.","journal-title":"Blood"},{"key":"1232_CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","volume":"84","author":"H Hsu","year":"1996","unstructured":"Hsu H, Shu HB, Pan MG, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299\u2013308.","journal-title":"Cell"},{"key":"1232_CR18","doi-asserted-by":"crossref","first-page":"40760","DOI":"10.1074\/jbc.M204351200","volume":"277","author":"AB Werner","year":"2002","unstructured":"Werner AB, de Vries E, Tait SW, Bontjer I, Borst J. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8\/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. J Biol Chem. 2002;277:40760\u20137.","journal-title":"J Biol Chem"},{"key":"1232_CR19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.semcdb.2005.02.010","volume":"16","author":"KI Nakayama","year":"2005","unstructured":"Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol. 2005;16:323\u201333.","journal-title":"Semin Cell Dev Biol"},{"key":"1232_CR20","doi-asserted-by":"crossref","unstructured":"Chan CH, Lee SW, Wang J, Lin HK. Regulation of Skp2 expression and activity and its role in cancer progression. Sci World J. 2010;10:1001\u201315.","DOI":"10.1100\/tsw.2010.89"},{"key":"1232_CR21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1097-2765(02)00467-7","volume":"9","author":"J Mendez","year":"2002","unstructured":"Mendez J, Zou-Yang XH, Kim SY, Hidaka M, Tansey WP, Stillman B. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Mol Cell. 2002;9:481\u201391.","journal-title":"Mol Cell"},{"key":"1232_CR22","doi-asserted-by":"crossref","first-page":"30854","DOI":"10.1074\/jbc.C300251200","volume":"278","author":"X Li","year":"2003","unstructured":"Li X, Zhao Q, Liao R, Sun P, Wu X. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Biol Chem. 2003;278:30854\u20138.","journal-title":"J Biol Chem"},{"key":"1232_CR23","doi-asserted-by":"crossref","first-page":"27315","DOI":"10.1074\/jbc.M314023200","volume":"279","author":"T Kondo","year":"2004","unstructured":"Kondo T, Kobayashi M, Tanaka J, Yokoyama A, Suzuki S, Kato N, et al. Rapid degradation of Cdt1 upon UV-induced DNA damage is mediated by SCFSkp2 complex. J Biol Chem. 2004;279:27315\u20139.","journal-title":"J Biol Chem"},{"key":"1232_CR24","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1101\/gad.1574507","volume":"21","author":"H Liu","year":"2007","unstructured":"Liu H, Cheng EH, Hsieh JJ. Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes Dev. 2007;21:2385\u201398.","journal-title":"Genes Dev"},{"key":"1232_CR25","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1128\/MCB.21.23.7956-7970.2001","volume":"21","author":"RE Kiernan","year":"2001","unstructured":"Kiernan RE, Emiliani S, Nakayama K, Castro A, Labbe JC, Lorca T, et al. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol Cell Biol. 2001;21:7956\u201370.","journal-title":"Mol Cell Biol"},{"key":"1232_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2005.02.014","volume":"7","author":"E Dehan","year":"2005","unstructured":"Dehan E, Pagano M. Skp2, the FoxO1 hunter. Cancer Cell. 2005;7:209\u201310.","journal-title":"Cancer Cell"},{"key":"1232_CR27","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1073\/pnas.0406789102","volume":"102","author":"H Huang","year":"2005","unstructured":"Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA. 2005;102:1649\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1232_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12185-007-0004-0","volume":"87","author":"H Yoshida","year":"2008","unstructured":"Yoshida H, Kitabayashi I. Chromatin regulation by AML1 complex. Int J Hematol. 2008;87:19\u201324.","journal-title":"Int J Hematol"},{"key":"1232_CR29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1349-7006.2007.00699.x","volume":"99","author":"K Sasaki","year":"2008","unstructured":"Sasaki K, Yamagata T, Mitani K. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. Cancer Sci. 2008;99:414\u201322.","journal-title":"Cancer Sci"},{"key":"1232_CR30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.1978.tb01713.x","volume":"5","author":"E Perucca","year":"1978","unstructured":"Perucca E, Gatti G, Frigo GM, Crema A. Pharmacokinetics of valproic acid after oral and intravenous administration. Br J Clin Pharmacol. 1978;5:313\u20138.","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1232-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1232-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1232-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T22:32:29Z","timestamp":1595111549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1232-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1232-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}